Coherus BioSciences, Inc.

NASDAQ:CHRS

0.82 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q1
Revenue 70.77464.97977.06391.52474.56858.71632.43645.35245.42460.15160.11573.37182.50387.64383.034110.419113.551135.674116.18123.856111.68483.43337.0980000001.3950.1610.844162.83514.06812.35910.1987.1676.8665.816.49316.0524.9653.5961.2320.5060.5070.506
Cost of Revenue 029.55536.09385.6332.70324.84816.87414.20235.23411.2779.3712.10421.2816.6967.51111.673910.1396.8557.8056.4470.6012.22526.66327.74126.51925.45530.9342.62633.253.77559.0164.57365.54465.31351.05168.21856.94436.46726.86718.49618.92513.9369.2224.9348.4678.656
Gross Profit 70.77435.42440.975.89441.86533.86815.56231.1510.1948.87450.74561.26761.22370.94775.52398.746104.551125.535109.325116.051105.23782.83234.873-26.663-27.741-26.519-25.455-30.93-42.626-31.805-53.614-58.16698.262-51.476-52.954-40.853-61.051-50.078-30.657-20.374-2.444-13.96-10.34-7.99-4.428-7.96-8.15
Gross Profit Ratio 10.5450.5320.0640.5610.5770.480.6870.2240.8130.8440.8350.7420.8090.910.8940.9210.9250.9410.9370.9420.9930.94000000-22.799-333.006-68.9170.603-3.659-4.285-4.006-8.518-7.294-5.277-3.138-0.152-2.812-2.875-6.485-8.751-15.7-16.107
Reseach & Development Expenses 21.67620.76826.96325.30525.64723.26734.15429.02245.80841.61182.91750.76254.08554.766203.49244.62838.85126.17333.10734.94821.56818.88318.78926.66231.60326.51925.45531.48842.62634.553.77559.0164.57365.54465.31351.43368.21856.94436.46726.86718.49618.92513.9369.2224.9348.9678.656
General & Administrative Expenses 000000043.12100041.35200037.69331.98434.05235.3536.0731.82836.45632.68333.8425.36918.39116.57714.97813.98923.53318.80315.29413.64511.2611.39810.97210.1668.8176.0916.1863.9793.9783.4212.4972.3551.3241.289
Selling & Marketing Expenses 000000010.50008.70003.80004.50002.800000000000000000000000
SG&A 34.74435.16549.73248.94948.22445.14449.15353.62144.83151.27648.75350.05239.92540.34539.39137.69331.98434.05235.3536.0731.82836.45632.68333.8425.36918.39116.57714.97813.98923.53318.80315.29413.64511.2611.39810.97210.1668.8176.0916.1863.9793.9783.4212.4972.3551.3241.289
Other Expenses 01.4672.869-0.1292.2531.6171.7282.0081.3390.4430.032-0.3850.030.0110.0610.0060.0560.4230.0680.7210.5180.5580.8110.340.5713.6420.138-0.2030.0143.62-0.029-0.1151.647-5.06-0.349-0.373-0.235-0.139-4.091-2.463-1.49-5.974-8.668-0.803-12.69800
Operating Expenses 56.4255.93376.69574.25473.87168.41183.30782.64390.63992.887131.67100.81494.0195.111242.88382.32170.83560.22568.45771.01853.39655.33951.47260.50256.97244.9142.03246.46656.61558.03372.57874.30478.21876.80476.71162.40578.38465.76142.55833.05322.47522.90317.35711.7197.2890.7490.712
Operating Income -6.387-20.509-35.725-68.36-32.006-34.543-67.745-51.493-80.449-44.013-80.925-39.547-32.787-24.164-167.3616.42533.71665.3140.86845.03351.84127.493-16.599-60.502-56.972-44.91-42.032-46.466-56.615-56.638-72.417-73.4684.617-62.736-64.352-52.207-71.217-58.895-36.748-26.56-6.423-17.938-13.761-10.487-6.783-9.284-9.439
Operating Income Ratio -0.09-0.316-0.464-0.747-0.429-0.588-2.089-1.135-1.771-0.732-1.346-0.539-0.397-0.276-2.0160.1490.2970.4810.3520.3640.4640.33-0.447000000-40.601-449.795-87.0380.52-4.459-5.207-5.119-9.937-8.578-6.325-4.091-0.4-3.613-3.827-8.512-13.405-18.312-18.654
Total Other Income Expenses Net -4.3647.588138.6-11.293-8.0151.617-7.984-7.377-6.201-6.137-15.159-0.3850.030.0110.0610.0060.0560.4230.0680.7210.5180.5580.8110.340.5713.6420.138-0.2030.0143.62-0.029-0.1151.647-5.06-0.349-0.373-0.235-0.139-4.091-2.463-1.49-5.974-8.668-0.803-12.6980.5750.577
Income Before Tax -10.751-12.921102.875-79.653-40.021-42.869-75.729-58.87-86.65-50.15-96.084-45.725-38.528-29.9-172.94710.7628.11660.32536.50541.27147.8923.618-20.004-62.596-58.826-43.685-44.302-49.069-58.993-55.402-74.822-75.94483.844-70.15-65.538-52.58-71.485-59.034-40.839-29.023-7.914-25.07-25.17-14.591-21.473-8.709-8.862
Income Before Tax Ratio -0.152-0.1991.335-0.87-0.537-0.73-2.335-1.298-1.908-0.834-1.598-0.623-0.467-0.341-2.0830.0970.2480.4450.3140.3330.4290.283-0.539000000-39.715-464.733-89.9810.515-4.986-5.303-5.156-9.974-8.598-7.029-4.47-0.493-5.049-6.999-11.843-42.437-17.178-17.514
Income Tax Expense 001.464-10.611-0.3811.56-0.9497.3776.2016.13715.1595.7935.8015.7585.7091.0520.1831.2940.9332.0440.8470.0515.0270.072.9786.0122.5410.1142.4025.9382.3030.4283.972-2.8890.3380.489-0.989-0.763-4.2050.155-1.531-4.929-5.9272.498-10.70600
Net Income -10.751-12.921102.875-79.653-39.641-42.869-74.78-66.247-92.851-56.287-111.243-45.725-38.528-29.9-172.9479.70827.93359.03135.57239.22747.04323.567-20.004-62.596-58.808-43.638-44.297-49.067-58.989-55.336-74.778-75.92183.939-69.967-65.388-52.391-71.334-58.81-40.725-29.134-7.872-24.957-25.17-14.591-21.473-8.709-8.862
Net Income Ratio -0.152-0.1991.335-0.87-0.532-0.73-2.305-1.461-2.044-0.936-1.851-0.623-0.467-0.341-2.0830.0880.2460.4350.3060.3170.4210.282-0.539000000-39.667-464.46-89.9540.515-4.973-5.291-5.137-9.953-8.565-7.009-4.487-0.49-5.027-6.999-11.843-42.437-17.178-17.514
EPS -0.093-0.110.91-0.71-0.41-0.49-0.94-0.85-1.19-0.73-1.44-0.6-0.49-0.4-2.370.130.390.830.50.560.670.34-0.29-0.92-0.87-0.68-0.74-0.84-1.09-1.08-1.54-1.711.93-1.72-1.67-1.35-1.86-1.56-1.22-1.47-0.25-1.38-1.39-0.81-1.19-2.8-3.14
EPS Diluted -0.093-0.110.82-0.71-0.41-0.49-0.94-0.85-1.19-0.73-1.44-0.6-0.49-0.4-2.370.120.330.70.480.530.630.32-0.29-0.92-0.87-0.68-0.74-0.84-1.09-1.08-1.54-1.711.67-1.72-1.67-1.35-1.86-1.56-1.22-1.47-0.25-1.38-1.39-0.81-1.19-2.8-3.14
EBITDA -6.387-19.322-34.218-67.297-32.006-32.046-66.017-49.485-78.115-42.683-80.126-39.932-31.865-23.276-166.4516.43134.46565.73341.54345.75452.35928.051-15.097-60.162-55.603-40.366-40.972-46.669-55.831-52.181-71.581-73.57587.017-67.067-63.984-52.207-71.452-59.034-40.607-29.023-7.721-23.781-22.313-11.182-19.38-9.185-9.343
EBITDA Ratio -0.09-0.297-0.444-0.735-0.429-0.546-2.035-1.091-1.72-0.71-1.333-0.544-0.386-0.266-2.0050.1490.3040.4840.3580.3690.4690.336-0.407000000-37.406-444.602-87.1740.534-4.767-5.177-5.119-9.97-8.598-6.989-4.47-0.481-4.79-6.205-9.076-38.3-18.116-18.464